Skip to main content
Zealand Pharma A/S (CPH:ZEAL)
Denmark flag Denmark · Delayed Price · Currency is DKK
234.90
-134.30 (-36.38%)
At close: Mar 6, 2026

Zealand Pharma Revenue

In the year 2025, Zealand Pharma had annual revenue of 9.21B DKK with 14,598.86% growth. Zealand Pharma had revenue of 68.92M in the quarter ending December 31, 2025, with 660.99% growth.

Revenue
9.21B
Revenue Growth
+14,598.86%
P/S Ratio
1.80
Revenue / Employee
18.77M
Employees
501
Market Cap
16.59B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20259.21B9.15B14,598.86%
Dec 31, 202462.69M-280.10M-81.71%
Dec 31, 2023342.79M238.80M229.65%
Dec 31, 2022103.99M-4.56M-4.20%
Dec 31, 2021108.55M-83.46M-43.47%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novo Nordisk 309.06B
Genmab 23.66B
Coloplast 27.89B
ALK-Abelló 6.31B
Demant 22.97B
H. Lundbeck 24.63B
Ambu A/S 6.09B
Bavarian Nordic 6.89B
Revenue Rankings

Zealand Pharma News

More News